20106 ⎘
Medicinal preparations characterised by special physical form; Pills, tablets, discs, rods; Excipients; Inactive ingredients; Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers Polyesters, e.g. poly(lactide-co-glycolide)
COMPOUND SLOW-RELEASE IMPLANT OF NALTREXONE AND RISPERIDONE, PREPARATION METHOD THEREFOR, AND USE THEREOF
#2Tamper-resistant drug dosage forms and methods of making and use thereof
#3BIODEGRADABLE COMPACTED FORMULATIONS AND METHODS OF USE AND MANUFACTURE THEREOF
#4METHODS OF TREATMENT OF OCULAR CONDITIONS WITH A SUSTAINED DRUG DELIVERY IMPLANT
#5PROTEIN AND PEPTIDE VACCINES TARGETING METHANOGENS
#6PHARMACEUTICAL FORMULATIONS OF GPR119 AGONISTS AND USES THEREOF
#7MICROMOTORS AND NANOMOTORS FOR GASTROINTESTINAL DIAGNOSIS AND TREATMENT APPLICATIONS
#8INTRAOCULAR PRESSURE REDUCTION WITH INTRACAMERAL BIMATOPROST IMPLANTS
#9OCULAR IMPLANT MADE BY A DOUBLE EXTRUSION PROCESS
#10POLYMERIC IMPLANTS WITH HIGH DRUG LOADING AND LONG-ACTING DRUG RELEASE AND METHODS OF MAKING THE SAME
#11IMMEDIATE RELEASE ABUSE-DETERRENT GRANULATED DOSAGE FORMS
#12DELIVERY DEVICES AND METHODS FOR MAKING THE SAME
#13DRUG DELIVERY AGENTS FOR PREVENTION OR TREATMENT OF PULMONARY DISEASE
#14OCULAR IMPLANT MADE BY A DOUBLE EXTRUSION PROCES
#15DELIVERY DEVICES AND METHODS FOR MAKING THE SAME
#16BIOERODIBLE DRUG DELIVERY DEVICES
#17INTRAOCULAR PRESSURE REDUCTION WITH INTRACAMERAL BIMATOPROST IMPLANTS
#18DRUG-CONTAINING IMPLANTS AND METHODS OF USE THEREOF
#19PHARMACEUTICAL COMPOSITION FOR TREATING LEVODOPA-INDUCED DYSKINESIA OR FOR SUP-PRESSING PROGRESSION THEREOF
#20Delayed release deferiprone tablets and methods of using the same
#21BIOERODIBLE DRUG DELIVERY DEVICES
#22Immediate release abuse-deterrent granulated dosage forms
#23POLYMERIC IMPLANTS WITH HIGH DRUG LOADING AND LONG-ACTING DRUG RELEASE AND METHODS OF MAKING THE SAME
#24DOSAGE FORM COMPRISING A POLYMERIC MATRIX
#25Biodegradable cationic polycarbonates as adjuvants for vaccines
#26Delayed release deferiprone tablets and methods of using the same
#27Tamper-resistant drug dosage forms and methods of making and use thereof
#28HYPOTENSIVE LIPID-CONTAINING BIODEGRADABLE INTRAOCULAR IMPLANTS AND RELATED METHODS
#29BIODEGRADABLE INTRAVITREAL TYROSINE KINASE IMPLANTS
#30OCULAR IMPLANT MADE BY A DOUBLE EXTRUSION PROCES
#31Immediate release abuse-deterrent granulated dosage forms
#32Dry Transfection Compositions and Methods for Making and Using the Same
#33SOLID DELIVERY COMPOSITION
#34DRUG-CONTAINING IMPLANTS AND METHODS OF USE THEREOF
#35Batch-wise melt extrusion process and device for preparing a solid dispersion
#36Delayed release deferiprone tablets and methods of using the same
#37Delayed release deferiprone tablets and methods of using the same
#38Delayed release deferiprone tablets and methods of using the same
#39Biodegradable block copolymer drug delivery composition
#40Pharmaceutical composition
#41PHARMACEUTICAL DOSAGE FORMS COMPRISING POLY(EPSILON-CAPROLACTONE) AND POLYETHYLENE OXIDE
#42Biodegradable block copolymer drug delivery composition
#43Radiation sterilization of hypercompresed polymer dosage forms
#44Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
#45Preparation method of naltrexone implants
#46Micromotors and nanomotors for gastrointestinal diagnosis and treatment applications
#47Hypotensive lipid-containing biodegradable intraocular implants and related methods
#48Delivery devices and methods for making the same
#49Extended release biodegradable ocular implants
#50Sustained-release pharmaceutical composition for treatment and prevention of eye disease
#51Gastric residence systems for sustained delivery of adamantane-class drugs
#52INJECTABLE SUSTAINED RELEASE DELIVERY DEVICES
#53SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND METHODS FOR TREATING OCULAR VASCULOPATHIES
#54Immediate release abuse-deterrent granulated dosage forms
#55Delayed release deferiprone tablets and methods of using the same
#56Prolonged Drug-Eluting Products
#57Delayed release deferiprone tablets and methods of using the same
#58Risperidone biodegradable implant
#59Biodegradable intravitreal tyrosine kinase implants
#60Ocular implant made by a double extrusion process
#61Radiation sterilization of hypercompressed polymer dosage forms
#62FLOATING PHARMACEUTICAL DOSAGE FORM
#63COMBINATION OF DRUGS HAVING DIFFERENT POTENCY
#64ABUSE DETERRENT PHARMACEUTICAL DOSAGE FORMS
#65Bioerodible drug delivery devices
#66Implantable Naltrexone tablets
#67INTRAOCULAR DRUG DELIVERY DEVICE AND ASSOCIATED METHODS
#68PRINTING DRUG TABLETS WITH FULLY CUSTOMIZABLE RELEASE PROFILES FOR PERSONALIZED MEDICINE
#69Hypotensive lipid-containing biodegradable intraocular implants and related methods
#70Anesthetic compositions and methods comprising imidazoline compounds
#719-OH-risperidone controlled release composition
#72Drug-containing PLA implants and methods of use thereof
#73Drug-containing implants and methods of use thereof
#74Pharmaceutical composition having abuse deterrent properties
#75Sustained-release pharmaceutical composition for treatment and prevention of eye disease
#76Method of making a poly(L-lactide) stent with tunable degradation rate
#77Intraocular drug delivery device and associated methods
#78COMPACTED SOLID DOSAGE FORM
#79Biopolymer-nanoparticle composite implant for tumor cell tracking
#80Immediate release abuse-deterrent granulated dosage forms
#81Controlled release composition
#82Drug-containing implants and methods of use thereof
#83Hypotensive lipid-containing biodegradable intraocular implants and related methods
#84Biodegradable intravitreal tyrosine kinase implants
#85Method of treating with poly(L-lactide) stent with tunable degradation rate
#86Methods and compositions for treating post-operative pain comprising clonidine
#87Ocular implant made by a double extrusion process
#88Pharmaceutical compositions resistant to abuse
#89Sustained release intraocular implants and methods for treating ocular vasculopathies
#90Compositions and methods for treating post-operative pain using clonidine and bupivacaine
#91Implants for the treatment of dopamine associated states
#92PHARMACEUTICAL DOSAGE FORMS COMPRISING POLY(EPSILON-CAPROLACTONE) AND POLYETHYLENE OXIDE
#93Extended release biodegradable ocular implants
#94Clonidine formulations in a biodegradable polymer carrier
#95Clonidine formulations in a biodegradable polymer carrier
#96METHODS OF TREATMENT OF OCULAR CONDITIONS WITH A SUSTAINED DRUG DELIVERY IMPLANT
#97Hypotensive lipid-containing biodegradable intraocular implants and related methods
#98Poly(L-lactide) stent with tunable degradation rate
#99Risperidone-containing implants and methods of use thereof
#100Steroid-containing sustained release intraocular implants and related methods
#101Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
#102Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
#103Extended release biodegradable ocular implants
#104Methods and compositions for treating post-operative pain comprising clonidine
#105Pharmaceutical compositions resistant to abuse
#106Extended release biodegradable ocular implants
#107Biodegradable intravitreal tyrosine kinase implants
#108Ocular implant made by a double extrusion process
#109Clonidine compounds in a biodegradable polymer
#110Risperidone-containing PLA:PGA implants and methods of use thereof
#111Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
#112Solid Pharmaceutical Dosage Formulation
#113Hypotensive prostamide-containing biodegradable intraocular implants and related methods
#114Hypotensive lipid-containing biodegradable intraocular implants and related methods
#115Compositions controlling pH range of release and/or release rate
#116Methods of treating ocular disease using steroid-containing sustained release intraocular implants
#117Stabilized biodegradable neurotoxin implants
#118IMPLANT PROCESSING METHODS FOR THERMALLY LABILE AND OTHER BIOACTIVE AGENTS AND IMPLANTS PREPARED FROM SAME
#119Ocular implant made by a double extrusion process
#120Ocular implant made by a double extrusion process
#121Controlled releasing composition
#122CLONIDINE FORMULATIONS HAVING ANTIMICROBIAL PROPERTIES
#123DELAYED RELEASE COMPOSITIONS
#124SELF EMULSIFYING GRANULES AND PROCESS FOR THE PREPARATION OF EMULSIONS THEREFROM
#125Method to make poly(L-lactide) stent with tunable degradation rate
#126PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF PARKINSON'S DISEASE AND RELATED DISORDERS
#127Polyinosinic acid-polycytidylic acid-based adjuvant
#128Intraocular pressure reduction with intracameral bimatoprost implants
#129System for controlled release of an active principle and method for preparation
#130Pharmaceutical compositions resistant to abuse
#131SLOW RELEASE MISOPROSTOL FOR OBSTETRIC AND/OR GYNAECOLOGICAL APPLICATIONS
#132IMPLANTS CONTAINING DISULFIRAM AND AN ANTI-INFLAMMATORY AGENT
#133Controlled release implantable dispensing device and method
#134Subcutaneous implants containing a degradation-resistant polylactide polymer
#135PROSTAGLANDIN AND PROSTAMIDE DRUG DELIVERY SYSTEMS AND INTRAOCULAR THERAPEUTIC USES THEREOF
#136Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
#137Poly (β-hydroxy short-medium chain fatty acid)
#138Stabilized biodegradable neurotoxin implants
#139MONOLITHIC DRUG DELIVERY SYSTEM
#140Methods and compositions for treating platelet-related disorders
#141Method of maintaining therapeutic risperidone levels in a PLA:PLGA implant
#142Methods and compositions for controlled delivery of phytochemical agents
#143Controlled release implantable dispensing device and method
#144Sulindac formulations in a biodegradable material
#145Methods and compositions for treating post-operative pain comprising clonidine
#146Clonidine formulations in a biodegradable polymer carrier
#147Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
#148Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
#149Compositions and methods for treating post-operative pain using clonidine and bupivacaine
#150Kinase inhibitors
#151FORMULATION FOR CONTROLLED RELEASE OF DRUGS BY COMBINING HYDROPHILIC AND HYDROPHOBIC AGENTS
#152Compositions controlling pH range of release and/or release rate
#153Long-Term Delivery Formulations and Methods of Use Thereof
#154Solid Pharmaceutical Dosage Formulation
#155Ocular implant made by a double extrusion process
#156Ocular implant made by a double extrusion process
#157Bioadhesive Rate-Controlled Oral Dosage Formulations
#158EXTENDED RELEASE BIODEGRADABLE OCULAR IMPLANTS
#159BIODEGRADABLE POLYPHOSPHATES COMPLEX FOR CONTROLLED RELEASE OF BIOACTIVE SUBSTANCES AND RELATED METHODS
#160METHODS FOR THE DELIVERY OF BIOACTIVE SUBSTANCES WITH BIODEGRADABLE POLYPHOSPHATES
#161Implants for the treatment of dopamine associated states
#162BIODEGRADABLE, ANIONIC POLYMERS DERIVED FROM THE AMINO ACID L-TYROSINE
#163METHODS FOR REDUCING NEOVASCULARIZATION OR EDEMA
#164Hypotensive lipid-containing biodegradable intraocular implants and related methods
#165Hypotensive lipid-containing biodegradable intraocular implants and related methods
#166FORMULATION FOR CONTROLLED RELEASE OF DRUGS BY COMBINING HYDROPHILIC AND HYDROPHOBIC AGENTS
#167Sustained release intraocular implants and methods for treating ocular vasculopathies
#168Sustained release intraocular implants and methods for treating ocular vasculopathies
#169Sustained release intraocular implants and methods for treating ocular vasculopathies
#170Methods and compositions for treating platelet-related disorders
#171Ocular implant made by a double extrusion process
#172RADIO-OPAQUE POLYMERIC BIOMATERIALS
#173Injectable sustained release delivery devices
#174Implants for the treatment of dopamine associated states
#175Botulinum toxin formulation for oral administration
#176Polyinosinic acid-polycytidylic acid-based adjuvant
#177PHARMACEUTICAL FORMULATIONS CONTAINING 5-CYCLOPROPYL-2-(4-FLUOROPHENYL)-6-[(2-HYDROXYETHYL)(METHYLSULFONYL)AMINO]-N-METHYL-1-BENZOFURAN-3-CARBOXAMIDE AND METHOD OF MAKING THE SAME
#178Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders
#179Long-acting solid formulation comprising triptorelin acetate
#180Steroid-containing sustained release intraocular implants and related methods
#181Bioresorbable hydrogel compositions for implantable prostheses
#182Compositions and methods for treating glaucoma
#183Beta hydroxy short to medium chain fatty acid polymer
#184Compositions and medical devices utilizing bioabsorbable polymeric waxes
#185Microimplants for ocular administration
#186Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
#187Drug Delivery Compositions and Related Methods
#188Radio-opaque polymeric biomaterials
#189Drug-containing implants and methods of use thereof
#190Drug-containing implants and methods of use thereof
#191Methods and compositions for delivery of catecholic butanes for treatment of obesity
#192Compositions and medical devices utilizing bioabsorbable polymeric waxes
#193Compositions and medical devices utilizing bioabsorbable polymeric waxes
#194Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
#195Controlled regional oral delivery
#196Methods for manufacturing delivery devices and devices thereof
#197Intraocular implants and methods for improving vision
#198Biodegradable intravitreal tyrosine kinase implants
#199Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
#200Extended release biodegradable ocular implants
#201Hypotensive lipid-containing biodegradable intraocular implants and related methods
#202Sustained release intraocular implants and methods for treating ocular vasculopathies
#203Compositions and medical devices utilizing bioabsorbable polymeric waxes and rapamycin
#204Compositions for treatment of central nervous system neoplasms, and methods of making and using the same
#205Stabilized biodegradable neurotoxin implants
#206Methods and compositions for treating platelet-related disorders
#207Bioadhesive polymers with catechol functionality
#208Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
#209Medical treatment system and production method therefor
#210Solid pharmaceutical dosage formulation
#211Biodegradable polyphosphates for controlled release of bioactive substances
#212Radio-opaque polymeric biomaterials
#213Controlled release formulation
#214Solid or semi-solid therapeutic formulations
#215Ocular implant made by a double extrusion process
#216Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
#217Tablets and methods for modified release of hydrophylic and other active agents
#218Bioresorbable hydrogel compositions for implantable prostheses
#219Biodegradable implant comprising a polylactide polymer and a lh-rh analogue
#220Injectable sustained release delivery devices